Cancer Institute A national cancer institute
designated cancer center
Profile http://med.stanford.edu/profiles/cancer/researcher/Linda_Boxer/
Email this profile
Portrait View Larger

Linda Boxer, MD, PhD

Academic Appointments

  • Vice Dean of the School of Medicine and Professor of Medicine (Hematology)

Key Documents

Contact Information

  • Clinical Offices
    Hematology Clinic 875 Blake Wilbur Dr Clinic C MC 5820 Stanford, CA 94305
    Tel Work (650) 498-6000 Fax (650) 723-1269
    Hematology Clinic 875 Blake Wilbur Dr Clinic C MC 5820 Stanford, CA 94305
    Tel Work (650) 498-6000 Fax (650) 723-1269
  • Academic Offices
    Personal Information
    Email Tel (650) 724-6966
    Alternate Contact
    Lisa Joo Executive Associate Tel Work 650-725-6762
    Not for medical emergencies or patient use

Professional Overview

Clinical Focus

  • Cancer> Hematology
  • Hematology
  • Multiple Myeloma
  • Multiple Myeloma - Medical Oncology
  • Plasmacytoma
  • Plasmacytoma - Hematology
View All 7clinical focus of Linda Boxer

Administrative Appointments

  • Chief, Division of Hematology, Stanford University School of Medicine (2004 - present)

Professional Education

Fellowship: Stanford University School of Medicine CA (1990)
Fellowship: Stanford University School of Medicine CA (1989)
Residency: Stanford University School of Medicine CA (1984)
Internship: Stanford University School of Medicine CA (1982)
Board Certification: Medical Oncology, American Board of Internal Medicine (1987)
Board Certification: Internal Medicine, American Board of Internal Medicine (1984)
View All 9

Courses

2013-14

Graduate and Fellowship Program Affiliations

Scientific Focus

Current Research and Scholarly Interests

We are studying the transcriptional deregulation of several oncogenes in human hematologic malignancies.

Activation of c-myc in Burkitt's lymphoma: We are examining the transcriptional deregulation of the translocated c-myc gene and the silencing of the normal c-myc gene in Burkitt's lymphoma. We are looking at the c-myc promoter and regions of the immunoglobulin locus that are responsible for the deregulation of the translocated c-myc gene. Several model systems have been designed.

Activation of bcl-2 in hematologic malignancies: In lymphomas with the t(14;18) translocation, the bcl-2 gene is translocated to the immunoglobulin locus and expressed at high levels. We are studying the mechanism of activation at a molecular level in human lymphoma tissue. We have also developed a model system to determine which region of the immunoglobulin locus is responsible for the activation of the translocated bcl-2 gene.

Expression profiling in ALL: We are examining gene expression profiles in acute lymphoblastic leukemia in response to chemotherapeutic agents.

Publications

Publication tag cloud

Publication Topics

View All 63

Stanford Medicine Resources:

Footer Links: